Barry L. Carter PharmD, FCCP, FAMA, FASH, FAPHA

Barry L. Carter, Pharm.D., FCCP, FAHA, FASH is the Patrick E. Keefe Professor in the Department of Pharmacy Practice and Science, College of Pharmacy and a Professor in the Department of Family Medicine in the Roy J. and Lucille A. Carver College of Medicine at the University of Iowa.

Dr. Carter received his B.S. in pharmacy from the University of Iowa in 1978 and his Pharm.D. from the Medical College of Virginia, Virginia Commonweath University in 1980. He completed a postdoctoral fellowship in Family Practice at the Univerity of Iowa in 1981. He has served on the faculties of the University of Iowa (1981-1988), University of Houston and the Baylor College of Medicine (1988-1991), University of Illinois at Chicago (1991-1995) and he was the Chairman of the Department of Pharmacy Practice at the University of Colorado (1995-2000). Carter returned to the University of Iowa in 2000 to focus on his research program.

Dr. Carter is an internationally recognized expert in hypertension and team-based care. He is the recipient of 4 NIH R01 grants totaling over $17 million since 2003. These grants have supported his research involving physician-pharmacist collaborative models to improve the treatment of hypertension, improving adherence to hypertension guidelines and strategies to provide continuity of care between inpatient and community settings. He has received several research achievement awards from the American College of Clinical Pharmacy, American Society of Health-System Pharmacists and the American Pharmacists Association.

Dr. Carter is a past President of the American College of Clinical Pharmacy. He is a Fellow in the American Heart Association Council on High Blood Pressure Research (FAHA), a Fellow in the American College of Clinical Pharmacy (FCCP) and a Fellow in the American Society of Hypertension (FASH). He is a board certified pharmacotherapy specialist. He was a member of the National Heart, Lung, and Blood Insititute’s Fifth, Sixth and Seventh Joint National Committees on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC-5, 6 & 7). He of the current national hypertension guideline committee (JNC-8) which is scheduled to be released in late 2012.